RTI Surgical (RTIX) Announces First Implantation of map3 Cellular Allogeneic Bone Graft in a Foot and Ankle Procedure
9/25/2013 9:23:36 AM
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, is pleased to announce the first implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant in a foot and ankle procedure.
Help employers find you! Check out all the jobs and post your resume.
comments powered by